Literature DB >> 24094525

Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors.

Anis Chaari1, Basma Mnif, Mabrouk Bahloul, Fouzia Mahjoubi, Kamilia Chtara, Olfa Turki, Nourhene Gharbi, Hedi Chelly, Adnene Hammami, Mounir Bouaziz.   

Abstract

OBJECTIVE: The aim of this study was to describe the epidemiological characteristics of Acinetobacter baumannii ventilator-associated pneumonia (VAP) and to identify factors predictive of a poor outcome.
METHODS: A retrospective study was conducted over 16 months in a Tunisian intensive care unit (ICU). All adult patients with A. baumannii VAP were included.
RESULTS: Ninety-two patients were included in they study; 41 (44.6%) were admitted because of multiple trauma. The mean age of the patients was 44.5±19.5 years. All patients needed mechanical ventilation on admission. The mean SAPS II score was 39±15. The mean delay before VAP onset was 8.1±4.7 days. On VAP onset, 57 patients (62%) developed septic shock. Only 14.2% of isolated strains were susceptible to imipenem; none were resistant to colistin. The mean duration of mechanical ventilation was 20±11 days. The mean duration of ICU stay was 24.3±18.7 days. ICU mortality was 60.9%. In the multivariate analysis, factors predictive of a poor outcome were previously known hypertension (odds ratio 5.8, 95% confidence interval 1.4-24.9; p=0.018) and VAP-related septic shock (odds ratio 8.5, 95% confidence interval 3-23.7; p<0.001).
CONCLUSION: A. baumannii VAP is associated with a high mortality. Hemodynamic impairment is predictive of a poor outcome.
Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acinetobacter baumannii; Epidemiology; Prognosis; Ventilator-associated pneumonia

Mesh:

Substances:

Year:  2013        PMID: 24094525     DOI: 10.1016/j.ijid.2013.07.014

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  16 in total

1.  Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii.

Authors:  William F Penwell; Adam B Shapiro; Robert A Giacobbe; Rong-Fang Gu; Ning Gao; Jason Thresher; Robert E McLaughlin; Michael D Huband; Boudewijn L M DeJonge; David E Ehmann; Alita A Miller
Journal:  Antimicrob Agents Chemother       Date:  2015-01-05       Impact factor: 5.191

2.  Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump.

Authors:  Xinlong He; Feng Lu; Fenglai Yuan; Donglin Jiang; Peng Zhao; Jie Zhu; Huali Cheng; Jun Cao; Guozhong Lu
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

3.  Droperidol as a potential inhibitor of acyl-homoserine lactone synthase from A. baumannii: insights from virtual screening, MD simulations and MM/PBSA calculations.

Authors:  Rajat Kumar Jha; Ekampreet Singh; Rameez Jabeer Khan; Ankit Kumar; Monika Jain; Jayaraman Muthukumaran; Amit Kumar Singh
Journal:  Mol Divers       Date:  2022-10-03       Impact factor: 3.364

4.  Draft Genome Sequence of an International Clonal Lineage 1 Acinetobacter baumannii Strain from Argentina.

Authors:  Elisabet Vilacoba; Maxime Déraspe; German M Traglia; Paul H Roy; María Soledad Ramírez; Daniela Centrón
Journal:  Genome Announc       Date:  2014-11-26

5.  Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia.

Authors:  Juthamas Inchai; Chaicharn Pothirat; Chaiwat Bumroongkit; Atikun Limsukon; Weerayut Khositsakulchai; Chalerm Liwsrisakun
Journal:  J Intensive Care       Date:  2015-03-02

6.  Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin.

Authors:  Rocío Álvarez-Marín; Rafael López-Rojas; Juan Antonio Márquez; María José Gómez; José Molina; José Miguel Cisneros; Carlos Ortiz-Leyba; Javier Aznar; José Garnacho-Montero; Jerónimo Pachón
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

7.  Subsequent Multidrug-Resistant Bacteremia Is a Risk Factor for Short-Term Mortality of Patients with Ventilator-Associated Pneumonia Caused by Acinetobacter baumannii in Intensive Care Unit: A Multicenter Experience.

Authors:  Mo-Han Ju; Yu-Long Yao; Chun-Ling Du; Shu Chen; Yuan-Lin Song
Journal:  Chin Med J (Engl)       Date:  2018-02-05       Impact factor: 2.628

8.  Retrospective Assessment of Ventilator-Associated Pneumonias due to Acinetobacter baumannii in an Oncology Hospital.

Authors:  Sevil Yesim Canturan; Nadim Yilmazer; Rukiye Sarikaya; Zuhal Avsar; Mustafa Ertek; Ilhan Uyaner
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-07-02

9.  Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.

Authors:  Sami Abdellatif; Ahlem Trifi; Foued Daly; Khaoula Mahjoub; Rochdi Nasri; Salah Ben Lakhal
Journal:  Ann Intensive Care       Date:  2016-03-31       Impact factor: 6.925

10.  Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study.

Authors:  Ahlem Trifi; Sami Abdellatif; Cyrine Abdennebi; Foued Daly; Rochdi Nasri; Yosr Touil; Salah Ben Lakhal
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-11-16       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.